Credit Suisse’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-354,010
Closed -$9.73M 4255
2022
Q3
$9.73M Buy
354,010
+56,320
+19% +$1.4M 0.01% 915
2022
Q2
$6.87M Sell
297,690
-38,280
-11% -$894K 0.01% 1108
2022
Q1
$7.32M Sell
335,970
-933,561
-74% -$19.4M 0.01% 1199
2021
Q4
$27.1M Buy
1,269,531
+362,999
+40% +$7.61M 0.01% 939
2021
Q3
$19M Buy
906,532
+155,500
+21% +$3.39M 0.01% 1105
2021
Q2
$17.3M Sell
751,032
-40,809
-5% -$939K 0.01% 1223
2021
Q1
$17.5M Buy
791,841
+601,732
+317% +$13.9M 0.01% 1233
2020
Q4
$3.54M Buy
190,109
+28,315
+18% +$465K ﹤0.01% 2376
2020
Q3
$2.35M Buy
161,794
+13,283
+9% +$169K ﹤0.01% 2309
2020
Q2
$1.66M Sell
148,511
-874,503
-85% -$9.82M ﹤0.01% 2529
2020
Q1
$10.2M Buy
1,023,014
+995,788
+3,657% +$13.9M 0.01% 1175
2019
Q4
$446K Sell
27,226
-46,590
-63% -$625K ﹤0.01% 3630
2019
Q3
$891K Sell
73,816
-26,184
-26% -$360K ﹤0.01% 3082
2019
Q2
$1.46M Buy
+100,000
New +$1.48M ﹤0.01% 2668

Other funds holding CHNG

Credit Suisse's CHNG Position: Q4 2022 in Review

Credit Suisse sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 354,010 shares — an estimated $9.73M sold.

Credit Suisse first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $27.1M in Q4 2021. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Credit Suisse reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Credit Suisse sold 354,010 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $9.73M.
  • Credit Suisse first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Credit Suisse's Change Healthcare Inc. Common Stock position peaked at $27.1M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.